Disease Info Card

Dermatofibrosis Lenticularis Disseminata

Information about Dermatofibrosis Lenticularis Disseminata: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Dermatofibrosis Lenticularis Disseminata

Most recent studies have shown that Dermatofibrosis Lenticularis Disseminata shares some biological mechanisms with albers-schonberg-disease, bone-diseases, bone-diseases-developmental, collagen-nevus-of-skin, connective-tissue-diseases, connective-tissue-nevus-nos, cutis-laxa, dermatologic-disorders, dysplasia, fibroma, hamartoma, histiocytoma-benign-fibrous, melanocytic-nevus, melorheostosis, osteopoikilosis-(disorder), osteosclerosis, pseudoxanthoma-elasticum, sclerosis, skin-diseases-genetic, skin-neoplasms.

Among the many pathways, these few ones have gauged particular interests from scientists studying Dermatofibrosis Lenticularis Disseminata, and have been seen in publications frequently: Cell Proliferation, Innervation, Mrna Stabilization, Pathogenesis, Tissue Morphogenesis, Wound Healing

Quite a number of genes have been found to play important roles in Dermatofibrosis Lenticularis Disseminata, such as ABCC6, ELN, EXT1, FABP6, FBN1, FGF2, ITGA2B, ITGB3, LEMD3, MFAP2, MRO, RAB8A, SMAD2, SMAD3. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.